PARP1-dependent DNA-protein crosslink repair
Zita Fábián,Ellen S Kakulidis,Ivo A Hendriks,Ulrike Kühbacher,Nicolai B Larsen,Marta Oliva-Santiago,Junhui Wang,Xueyuan Leng,A Barbara Dirac-Svejstrup,Jesper Q Svejstrup,Michael L Nielsen,Keith Caldecott,Julien P Duxin
DOI: https://doi.org/10.1038/s41467-024-50912-x
2024-08-05
Abstract:DNA-protein crosslinks (DPCs) are toxic lesions that inhibit DNA related processes. Post-translational modifications (PTMs), including SUMOylation and ubiquitylation, play a central role in DPC resolution, but whether other PTMs are also involved remains elusive. Here, we identify a DPC repair pathway orchestrated by poly-ADP-ribosylation (PARylation). Using Xenopus egg extracts, we show that DPCs on single-stranded DNA gaps can be targeted for degradation via a replication-independent mechanism. During this process, DPCs are initially PARylated by PARP1 and subsequently ubiquitylated and degraded by the proteasome. Notably, PARP1-mediated DPC resolution is required for resolving topoisomerase 1-DNA cleavage complexes (TOP1ccs) induced by camptothecin. Using the Flp-nick system, we further reveal that in the absence of PARP1 activity, the TOP1cc-like lesion persists and induces replisome disassembly when encountered by a DNA replication fork. In summary, our work uncovers a PARP1-mediated DPC repair pathway that may underlie the synergistic toxicity between TOP1 poisons and PARP inhibitors.